We have developed an in situ bioprinting method that allows the printing of cells under true physiological conditions by applying self-assembling ultrashort peptides as bioinks. This method avoids cell stressing methods, such as UV-treatment, chemical crosslinking and viscous bioink printing methods. We further demonstrate that different nanomaterials can easily be synthesized or incorporated in the 3D bioprinted peptide scaffolds which opens up the possibility of functionalized 3D scaffolds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d0tb02424d | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
3D bio-printed proteinaceous bioactive scaffold loaded with dual growth factor enhanced chondrogenesis and in situ cartilage regeneration.
Bioact Mater
April 2025
Department of Regenerative Medicine, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
Articular cartilage has a limited self-healing capacity, leading to joint degeneration and osteoarthritis over time. Therefore, bioactive scaffolds are gaining attention as a promising approach to regenerating and repairing damaged articular cartilage through tissue engineering. In this study, we reported on a novel 3D bio-printed proteinaceous bioactive scaffolds combined with natural porcine cancellous bone dECM, tempo-oxidized cellulose nanofiber (TOCN), and alginate carriers for TGF-β1, FGF-18, and ADSCs to repair cartilage defects.
View Article and Find Full Text PDFHierarchy Reproduction: Multiphasic Strategies for Tendon/Ligament-Bone Junction Repair.
Biomater Res
January 2025
Academy of Orthopedics, Guangdong Province, Orthopedic Hospital of Guangdong Province, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510665, P. R. China.
Tendon/ligament-bone junctions (T/LBJs) are susceptible to damage during exercise, resulting in anterior cruciate ligament rupture or rotator cuff tear; however, their intricate hierarchical structure hinders self-regeneration. Multiphasic strategies have been explored to fuel heterogeneous tissue regeneration and integration. This review summarizes current multiphasic approaches for rejuvenating functional gradients in T/LBJ healing.
View Article and Find Full Text PDFThree-dimensional bioprinting utilizing sacrificial material support and longitudinal printability evaluation through volumetric imaging.
Biomater Adv
January 2025
Hangzhou Dianzi University, Automation College, Hangzhou, Zhejiang, China; Zhejiang Provincial Key Laboratory of Medical Information and Biological 3D Printing, Hangzhou, Zhejiang, China. Electronic address:
In three-dimensional (3D) bioprinting, the internal channel network is vital for nutrient and oxygen transport, crucial for cell survival and tissue construction. However, bioinks' poor mechanical properties hinder precise control over these networks. Advancements in 3D printing strategies, structure characterization, and deformation monitoring can improve hydrogel scaffolds with interconnected channels.
View Article and Find Full Text PDFReproducible, Scale-Up Production of Human Brain Organoids (HBOs) on a Pillar Plate Platform via Spheroid Transfer.
Methods Mol Biol
January 2025
Bioprinting Laboratories Inc., Dallas, TX, USA.
Human brain organoids (HBOs) derived from pluripotent stem cells hold great potential for disease modeling and high-throughput compound screening, given their structural and functional resemblance to fetal brain tissues. These organoids can mimic early stages of brain development, offering a valuable in vitro model to study both normal and disordered neurodevelopment. However, current methods of generating HBOs are often low throughput and variable in organoid differentiation and involve lengthy, labor-intensive processes, limiting their broader application in both academic and industrial research.
View Article and Find Full Text PDFReproducible, Scale-Up Production of Human Liver Organoids (HLOs) on a Pillar Plate Platform via Microarray 3D Bioprinting.
Methods Mol Biol
January 2025
Department of Biomedical Engineering, University of North Texas, Denton, TX, USA.
Human liver organoids (HLOs) derived from pluripotent stem cells hold potential for disease modeling and high-throughput compound screening due to their architectural and functional resemblance to human liver tissues. However, reproducible, scale-up production of HLOs for high-throughput screening (HTS) presents challenges. These include the high costs of additives and growth factors required for cell differentiation, variability in organoid size and function from batch to batch, suboptimal maturity of HLOs compared to primary hepatocytes, and low assay throughput due to excessive manual processes and the absence of assay-ready plates with HLOs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!